ANDA Approval Package – Naltrexone ER Injectable Suspension (ANDA 213195)

ANDA Approval Package – Naltrexone ER Injectable Suspension (ANDA 213195)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Request Contents: ANDA 213195 approval package for Naltrexone for Extended-Release Injectable Suspension, 380 mg/vial, Single-Dose Vial
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details